This protein family is endemic to Kinetoplastids, might have emerged de novo and also expanded. . The family also contains Leishmaniid members lacking the signal peptide and only having an MTTPA- start sequence
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 2, no: 9 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: A4HTK7
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 133 | 137 | PF00656 | 0.692 |
CLV_NRD_NRD_1 | 101 | 103 | PF00675 | 0.528 |
CLV_NRD_NRD_1 | 109 | 111 | PF00675 | 0.477 |
CLV_NRD_NRD_1 | 161 | 163 | PF00675 | 0.432 |
CLV_NRD_NRD_1 | 69 | 71 | PF00675 | 0.401 |
CLV_PCSK_FUR_1 | 99 | 103 | PF00082 | 0.501 |
CLV_PCSK_KEX2_1 | 101 | 103 | PF00082 | 0.527 |
CLV_PCSK_KEX2_1 | 109 | 111 | PF00082 | 0.476 |
CLV_PCSK_KEX2_1 | 163 | 165 | PF00082 | 0.426 |
CLV_PCSK_PC1ET2_1 | 163 | 165 | PF00082 | 0.416 |
CLV_PCSK_SKI1_1 | 31 | 35 | PF00082 | 0.612 |
CLV_PCSK_SKI1_1 | 70 | 74 | PF00082 | 0.405 |
DEG_MDM2_SWIB_1 | 34 | 42 | PF02201 | 0.378 |
DOC_CKS1_1 | 1 | 6 | PF01111 | 0.432 |
DOC_MAPK_RevD_3 | 149 | 164 | PF00069 | 0.606 |
DOC_USP7_MATH_1 | 118 | 122 | PF00917 | 0.723 |
DOC_USP7_MATH_1 | 15 | 19 | PF00917 | 0.389 |
DOC_USP7_UBL2_3 | 73 | 77 | PF12436 | 0.576 |
LIG_14-3-3_CanoR_1 | 109 | 114 | PF00244 | 0.681 |
LIG_14-3-3_CterR_2 | 162 | 166 | PF00244 | 0.653 |
LIG_EVH1_2 | 29 | 33 | PF00568 | 0.392 |
LIG_FHA_1 | 38 | 44 | PF00498 | 0.295 |
LIG_FHA_2 | 137 | 143 | PF00498 | 0.629 |
LIG_FHA_2 | 8 | 14 | PF00498 | 0.415 |
LIG_FHA_2 | 95 | 101 | PF00498 | 0.638 |
LIG_GBD_Chelix_1 | 50 | 58 | PF00786 | 0.256 |
LIG_LIR_Gen_1 | 143 | 154 | PF02991 | 0.616 |
LIG_LIR_Gen_1 | 18 | 29 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 143 | 149 | PF02991 | 0.653 |
LIG_LIR_Nem_3 | 18 | 24 | PF02991 | 0.425 |
LIG_LIR_Nem_3 | 82 | 88 | PF02991 | 0.651 |
LIG_Pex14_2 | 34 | 38 | PF04695 | 0.403 |
LIG_PTB_Apo_2 | 80 | 87 | PF02174 | 0.594 |
LIG_SH2_CRK | 21 | 25 | PF00017 | 0.418 |
LIG_SH2_CRK | 39 | 43 | PF00017 | 0.235 |
LIG_SH2_PTP2 | 146 | 149 | PF00017 | 0.634 |
LIG_SH2_PTP2 | 53 | 56 | PF00017 | 0.398 |
LIG_SH2_STAT3 | 66 | 69 | PF00017 | 0.648 |
LIG_SH2_STAT5 | 146 | 149 | PF00017 | 0.634 |
LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.416 |
LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.359 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.676 |
LIG_SH3_3 | 150 | 156 | PF00018 | 0.640 |
LIG_SH3_3 | 9 | 15 | PF00018 | 0.450 |
LIG_SUMO_SIM_anti_2 | 40 | 46 | PF11976 | 0.300 |
LIG_TYR_ITIM | 19 | 24 | PF00017 | 0.392 |
MOD_CK1_1 | 103 | 109 | PF00069 | 0.688 |
MOD_CK1_1 | 135 | 141 | PF00069 | 0.733 |
MOD_CK2_1 | 102 | 108 | PF00069 | 0.794 |
MOD_CK2_1 | 118 | 124 | PF00069 | 0.602 |
MOD_CK2_1 | 136 | 142 | PF00069 | 0.758 |
MOD_CK2_1 | 7 | 13 | PF00069 | 0.419 |
MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.453 |
MOD_GlcNHglycan | 132 | 135 | PF01048 | 0.433 |
MOD_GSK3_1 | 100 | 107 | PF00069 | 0.709 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.680 |
MOD_GSK3_1 | 130 | 137 | PF00069 | 0.730 |
MOD_GSK3_1 | 90 | 97 | PF00069 | 0.721 |
MOD_PIKK_1 | 94 | 100 | PF00454 | 0.708 |
MOD_PKA_1 | 101 | 107 | PF00069 | 0.686 |
MOD_PKA_1 | 109 | 115 | PF00069 | 0.677 |
MOD_PKA_2 | 100 | 106 | PF00069 | 0.683 |
MOD_PKA_2 | 108 | 114 | PF00069 | 0.692 |
MOD_PKB_1 | 99 | 107 | PF00069 | 0.716 |
MOD_Plk_4 | 109 | 115 | PF00069 | 0.638 |
MOD_Plk_4 | 15 | 21 | PF00069 | 0.432 |
MOD_Plk_4 | 29 | 35 | PF00069 | 0.369 |
TRG_ENDOCYTIC_2 | 146 | 149 | PF00928 | 0.645 |
TRG_ENDOCYTIC_2 | 21 | 24 | PF00928 | 0.523 |
TRG_ENDOCYTIC_2 | 39 | 42 | PF00928 | 0.293 |
TRG_ENDOCYTIC_2 | 53 | 56 | PF00928 | 0.356 |
TRG_ER_diArg_1 | 161 | 164 | PF00400 | 0.652 |
TRG_NLS_MonoExtC_3 | 69 | 74 | PF00514 | 0.635 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P923 | Leptomonas seymouri | 43% | 79% |
A0A3S5H659 | Leishmania donovani | 96% | 99% |
A0A3S7WQ87 | Leishmania donovani | 30% | 100% |
A4H5C6 | Leishmania braziliensis | 39% | 100% |
A4H5C7 | Leishmania braziliensis | 58% | 100% |
A4HTK6 | Leishmania infantum | 30% | 100% |
E9AMD7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 36% | 100% |
E9AMD8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 76% | 99% |
Q4QIB1 | Leishmania major | 85% | 100% |
Q4QIB2 | Leishmania major | 36% | 100% |